Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Tags
Checkpointhämmare
Tag: Checkpointhämmare
BioInvent soon has five drug candidates in six clinical studies
1 September, 2023
BioInvent’s CMO comments on phase I/IIa data with BI-1808
27 June, 2023
BioInvent ready for combination studies with BT-001
5 June, 2023
BioInvent reports clinical progress with BI-1206
21 April, 2023
One-on-one with Annexin Pharmaceuticals’ new CFO
11 April, 2023
BioInvent’s CEO expects eventful 2023
1 March, 2023
Annexin’s CEO: “The cancer area more than doubles the potential”
6 February, 2023
Ultimovacs protects cancer vaccine technology until 2037
26 April, 2022
Ultimovacs on track to develop universal cancer vaccine
24 September, 2020